Skip to main content

Endo dismisses lawsuit against the FDA after two-year battle

The two-year court battle centered on the bulk compounding of the active ingredient in Endo's blood pressure medicine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.